Clinical practice. Fibroblast growth factor (FGF)23: a new hormone (Q37824821)

23 August 2017

1 reference

title

Clinical practice. Fibroblast growth factor (FGF)23: a new hormone (English)

1 reference

23 August 2017

Uri S Alon

1

1 reference

23 August 2017

31 December 2010

1 reference

European Journal of Pediatrics

23 August 2017

1 reference

23 August 2017

170

1 reference

23 August 2017

5

1 reference

23 August 2017

545-554

1 reference

https://scigraph.springernature.com/pub.10.1007/s00431-010-1382-5

23 August 2017

0 references

cites work

Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

KLOTHO allele status and the risk of early-onset occult coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Association of human aging with a functional variant of klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Subclinical atherosclerosis and related risk factors in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Hypophosphatemia induced in mice by transplantation of a tumor-derived cell line from a patient with oncogenic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Recent advances in renal phosphate handling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Cinacalcet in the management of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

FGF-23 is elevated by chronic hyperphosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Renal allograft calcification -- prevalence and etiology in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Incidence and predictors of fractures in children after solid organ transplantation: a 5-year prospective, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Overview of the FGF23-Klotho axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Suppression of aging in mice by the hormone Klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Relationship between circulating FGF23 and total body atherosclerosis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

A rat model of chronic kidney disease-mineral bone disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Fibroblast growth factor 23: the making of a hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Dual functional roles of dentin matrix protein 1. Implications in biomineralization and gene transcription by activation of intracellular Ca2+ store

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Genetic disorders of renal phosphate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Endocrine functions of bone in mineral metabolism regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Renal tubular dysfunction following kidney transplantation: a prospective study in 31 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Hypophosphatemia: the common denominator of all rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Klotho converts canonical FGF receptor into a specific receptor for FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Bone health in children and adolescents after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Serum FGF23 levels in normal and disordered phosphorus homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Forging forward with 10 burning questions on FGF23 in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1382-5

A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis

21 January 2018

1 reference

12 December 2020

Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder

1 reference

12 December 2020

Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease

1 reference

12 December 2020

FGF-23 Levels before and after Renal Transplantation

1 reference

12 December 2020

The parathyroid is a target organ for FGF23 in rats

1 reference

12 December 2020

Histologic evolution of bone disease 6 months after successful kidney transplantation

1 reference

12 December 2020

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

1 reference

12 December 2020

Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis

1 reference

12 December 2020

Hypophosphataemia after renal transplantation: relationship to immunosuppressive drug therapy and effects on muscle detected by 31P nuclear magnetic resonance spectroscopy

1 reference

12 December 2020

Antacid-induced rickets in infancy

1 reference

12 December 2020

Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients

1 reference

12 December 2020

Tumour-induced rickets: a case report and review of the literature.

1 reference

12 December 2020

Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia

1 reference

12 December 2020

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

1 reference

12 December 2020

Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure.

1 reference

12 December 2020

Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats

1 reference

12 December 2020

Post-transplant hypophosphatemia

1 reference

12 December 2020

Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome

1 reference

12 December 2020

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

12 December 2020

Genetic transmission of tumoral calcinosis: autosomal dominant with variable clinical expressivity

1 reference

12 December 2020

Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?

1 reference

12 December 2020

Effects of reduced protein intake in rats with congenital polycystic kidney without renal failure

1 reference

12 December 2020

Risk of hip fracture among dialysis and renal transplant recipients

1 reference

12 December 2020

A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis

1 reference

12 December 2020

10.1007/S00431-010-1382-5

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21193927